chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe dizziness, tingling hands, feet, scalp, rapid heart rate, fainted.
About 5 minutes after administration, patient felt dizzy and lethargic. He stated no difficulty breathing but another 5 minutes elapsed before patient stated maybe some slight difficulty breathing. Paramedics were called and he opted to be taken in.
Patient returned to the hospital just 3 days after discharging. Generalized anxiety disorder, Attention deficit disorder, unspecified hyperactivity presence, High risk medication use (polypharmacy with multiple controlled substances), Bipolar 2 disorder. Treated in behavioral health and released. ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 25-SEP-2014, the patient was vaccinated with PNEUMOVAX 23 0.5, intramuscular, lot # J009827, expiration date 10-AUG-2014. Secondary and concomitant therapies were not reported. Pharmacist reported that patient was inadvertently administered PNEUMOVAX 23 that expired on 10-AUG-2014. No adverse effects reported. Additional information has been requested.
Patient was coughing for a bit, then start to grabbing her chest .  She did not want us to give epi pen or call Emergency dept.  She refused all the treatment but accepted bedadryl and hydroxyzine liquid for her itching.
right armpit is swollen.; Nausea; Achy; Tired; This case was reported by a consumer via call center representative and described the occurrence of nausea in a 71-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 7th September 2021, the patient received the 1st dose of Shingrix (intramuscular). On 7th September 2021, 10 hrs after receiving Shingrix, the patient experienced nausea, pain and tiredness. On 9th September 2021, the patient experienced local swelling. On an unknown date, the outcome of the nausea, pain and tiredness were recovered/resolved and the outcome of the local swelling was not recovered/not resolved.   It was unknown if the reporter considered the nausea, pain, tiredness and local swelling to be related to Shingrix.  Additional details were provided as follows: The patient reported the case for herself. The patient received Shingrix vaccine in right arm and she felt nausea, achy and tired about 10 hours later, then by the next morning those symptoms subsided. The patient stated that 2 days after dose her right armpit is swollen. The reporter consented to follow up. This case has been linked with case US2021192877, reported by the same reporter; Sender's Comments:  US-GLAXOSMITHKLINE-US2021192877:same reporter
Itchy arm followed by a 2 inch diameter red rash with itchiness the next day.
Information has been received from a physician concerning a 10 year old male who on 09-MAR-2000 and 03-SEP-2003 was vaccinated with the first and second doses of MMR II (LOT # not reported).  On 20-NOV-2009, the patient was diagnosed with mumps.  On 16-DEC-2009 the patient experienced mumps.  The patient was afebrile.  The blood work was done on 20-NOV-2009 and the results indicated IgM 0.34, IgG 3.81, and serum amylase 176.  The patient's outcome was unknown, this case was non-serious.  Follow-up information has been received from a physician concerning a 10 year old male who on 09-MAR-2000 and 03-SEP-2003 was vaccinated with the first and second doses of MMR II (LOT# not reported).  On 18-DEC-2009 the patient experienced mumps and on 20-DEC-2009 was diagnosed.  The patient had a parotitis.  The blood work results was not reported.  At the time of the report, the patient's outcome was unknown.  Additional information has been requested.
Soldier developed dew drop vesicles on an erythematous base unevenly distributed over face, head, chest, back and left hand (palmar aspect). Then developed mumps like illness associated with left parotid swelling and severe pain. Soldier recovered uneventfully after 4 weeks.
pt recvd 2nd dose of Hep B vax on 29JAN92; pt exp stinging pain @ the inject; pain persisted a few seconds;
Patient received the pediatric dose for the second shot. Patient's mother, was informed regarding this error. Her initial dose was the adult dose of Pfizer vaccine.
Red lump showed up on left arm the morning after vaccination. Arm remained sore and swollen for 5 days, after this the lump went away. On 2/18/21 left arm started itching where vaccine was given, and the morning of 2/19/21 red lump and soreness returned.
Onset of paleness, SOB, glazed eyes 1 1/2 hrs p/receiving vax; Seen @ ER;
This spontaneous report was received from a registered pharmacist refers to a 69 years old female patient who on 15-OCT-2012, was vaccinated subcutaneously on her right arm with a 0.65 ml dose of ZOSTAVAX (lot number H011427, Exp. Date: 12-SEP-2013). No other co-suspects were reported. No concomitant medications were reported. The pharmacist reported that on 17-OCT-2012, the patient called the pharmacy stating she had swollen lymph nodes under her right armpit, and a red, swollen area at the injection site of the right arm. BENADRYL was given as a treatment for the experience. At the time of the report, the patient had not recovered. The patient sought medical attention by calling to pharmacy this morning on 17-SEP-2012. The relatedness for patient had swollen lymph nodes under right armpit, swollen and red area at injection site was unknown for ZOSTAVAX. Additional information has been requested.
Developed a baseball sized lump in both sides of underarm area; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area). At the time of the report, AXILLARY MASS (Developed a baseball sized lump in both sides of underarm area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medication were provided. No treatment information was provided.
Began running fever right at 12 hours post vaccination. Injection site/left arm became so painful that I could not move it or lay comfortably on my left side or on my back.  General malaise, body aches, fatigue, and fever continued  until about 48 hours post-vaccination.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. Relevant medical history and concomitant medication were not provided. On 26-FEB-2014 the patient was vaccinated with GARDASIL. Lot number, dose, route and frequency were not provided. The vaccine was exposed to 56F for 10 days, an excursion that was found to be unsupported by in-house stability data. No adverse event was reported. Additional information has been requested.
About 12 hours after 3/4 vaccine, began to experience intense flare-up of neuropathic pain in dropped R foot, especially around large R toe. Went to bed. Woke up in pain around 3 am on 3/5. Drank water. Applied Castor oil and Arnica. No sound sleep rest of night. On rising, showered. Heat helped a bit. Drank more water. Applied more Castor oil and Arnica. Pulsing electrical/spasm-like pain continued in R foot, especially between big toe and 2nd toe.  Though felt vaguely nauseous, ate and stayed hydrated. Could not work. Laying down and warming, elevating foot helped. Around 9 pm on 3/5, intense flare-up began to subside.
Pt symptoms are redness and swollen approximately 6cm x 6cm area -> improved some with warm compress.
Also a very little itch; Few days later noted redness in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm). At the time of the report, VACCINATION SITE PRURITUS (Also a very little itch) and VACCINATION SITE ERYTHEMA (Few days later noted redness in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
I was tired and achey for one day (as we were warned). It messed up; my menstrual cycle on April 21. That's it! Please ask about menstrual cycles in future pharmaceutical trials. Women's health care matters.
Day after vaccination (1/28, less than 24 hour post injection) I discovered a rash on my right elbow as well as my left buttock cheek.  Rash was mildly itchy on my elbow, which is what drew attention my to it.  The rash on my left buttock cheek was very itchy, slightly more elevated, but still very similar in appearance to my elbow.  The rash on my elbow has grown from  the size of a quarter to about 2-3".  The rash on butt check has remained size of a quarter.  On 1/31 (4 days post vaccination), I discovered a similar rash on my left elbow, about the size of a quarter.   I have never had injection reactions previously, and when I have had rashes in the past, they were contact rashes.  Today is 2/1, 5 days post injection, and rashes are still relevant and visible.  I will apply a topical ointment today, but have not used anything to this point in time.   On a side note, I also experienced mild pain at the injection site 18-36 hours post injection.  This was not unexpected, required no attention on my part, and dissipated within 36 hours of injection.
Information has been received from a registered nurse referring to an unspecified patient of unknown age. On an unspecified date since 13-JUL-2015 the patient was vaccinated with an improperly stored dose of PROQUAD (Merck) (lot number and expiration date unknown). No adverse effect reported. The outcome was unknown. Additional information has been requested.
Low grade fever x 24 hours beginning 1 day after; Irritability and unconsolable crying for 3 days; Urticarial rash for 48 hours beginning 48 hours after.
c/o numbness & tingling in arm & hand;arm & hand go to sleep-pain in arm if pt lies on that side;saw PMD 17DEC96 given med;
FLUZONE HD was given on 10/21/15 and patient returned to pharmacy 11/18/15 and complained that arm still hurts.
Received DTaP 7-29-05, then developed swelling at site of injection (Left thigh) on 7-30-05, no fever, no pain. Area is warm to touch and measures 3-4 cm erythema.  Treated per doctor with Benadryl 12.mg/5ml  give 5 ml po qid prn and Motrin 100mg/5ml, give 4ml po q 8 hr. prn.
On the night of my vaccine, 04-06-2021, I experienced chills all night long. I also had a terrible headaches, SOB, chest pain. I also experienced light headiness which lasted one week. I went to see a doctor on 04-13-2021, who performed x-rays of the chest, did lab work and did an EKG which the tests came back normal. To this day I still have light headiness, nausea and light-headiness.
Patient with syncope after vaccination. No prior history. Given juice, crackers and rest. BP initially soft, but improved after 10 minutes. Patient able to leave asymptomatic prior to discharging home.
heart started beating a lot faster than usual; A spontaneous report was received from a consumer concerning a 77-year-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced heart beating a lot faster than usual (tachycardia).  The patient's medical history was not provided. Concomitant medications reported included medicine for blood pressure and cholesterol (medication names not specified).   On 17-Feb-2021, the patient received their first of two planned doses of mRNA-1273 (Lot # 006M20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.   On 18-Feb-2021, the patient experienced heart beating a lot faster than usual. Treatment was not taken for the symptoms.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event, heart beating a lot faster than usual,  was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Very limited information regarding this event/s has been provided at this time. Further information has been requested.
Received 3 vaccines at well check-up on 12-3-07.  About 24 hours later developed a diffuse red raised urticarial rash and mother took to ER.  She received IM dexamethasone, oral Benadryl.  She was sent home on oral Benadryl & oral Prednisolone.  On 12-7-07 mother reports no more rash.
pt devel total body rash on 24AUG96 (3-7mm red papules & macule);pt was treated w/oral DPH;
Upper respiratory  infection for 2 weeks duration, then sinus infection for another 2 weeks.
Nausea. BP 131/79; HR 72; RR 14. Gave water. Rested in med bay for 20 min. Pt stable & released from vaccination site
On June 27th, I had Oculosympathetic Palsy and found out I had an aneurism in my neck and dissected my left vertebral artery. I had multiple MRAs and am also on a baby aspirin for life now. I went to the ER at the hospital when I had this occur. Note, I had my DTAP vaccine; it was about 2-3 weeks after my 2nd dose of COVID vaccine. Pregnancy history, third; and all three born during C-section; this one's date of birth June 21st; 9 lbs and 6 ounces.
10/7/15-Rapid onset of light headed, weakness and "warmth" loose stool and vomiting. Went to leave work and developed blurred vision (bilat) lasting approximately 5 mins. Family picked her up b/c not able to drive, layed down prior to leaving. "Shivering" and "chills"  no temp checked. Felt "clammy". Felt over all achiness especially behind eyes. Symptoms resolved by 10/9/15.
Swelling & heat around lt shoulder - itching; (missed 2-3 days of work);
Immediate pain upon injection and administration of vaccine.  Arm was sore but usable until about 5 hours afterward.  I was unable to lift arm without assistance.  This has progressively gotten better but still have some "nerve" pain associated with moving arm a certain way. Greater than 48 hours after vaccine administration, I had an episode of angioedema (mine is idiopathic) involving left foot, left cheek and lip which moved to right cheek and lip.
Now its got the lumps going down it and they are tender; Now they are going down the other arm/lumps on her arms; Now its got the lumps going down it and they are tender; Now they are going down the other arm/lumps on her arms; caller asks does Pfizer have options to get rid of the swelling; This is a spontaneous report from a contactable consumer, the patient. An 84-year-old female patient received BNT162B2 (Pfizer BioNTech Covid 19 mRNA VACCINE BIONTECH), dose 2 via an unspecified route of administration, administered in Arm Right on 21May2021 (Batch/Lot Number: EW0161) (at the age of 84-year-old) as 2nd dose, single dose for covid-19 immunisation. Medical history included ongoing Afib (diagnosed with Afib five years ago) and memory problems. The patient's concomitant medications were not reported. The patient previously received BNT162B2 (Pfizer BioNTech Covid 19 mRNA VACCINE BIONTECH), dose 1 administered in Arm left on 30Apr2021 (Batch/Lot Number: EW0158) for covid-19 immunisation and had lumps down the front of the arm. The patient did not receive any other vaccines within four weeks prior to the vaccination. No additional vaccines administered on same date of the Pfizer suspect. On 22May2021, the patient reported now it got the lumps going down it and they are tender. The patient went ahead and received the second dose Pfizer Covid 19 Vaccine and now its got the lumps going down it and they are tender. They are not really going down, still there. Wondering if there was some kind of anecdote to take care of it? The right arm was not as serious. The marks or lumps are sort of in the same places on both arms, like in the bend of the arm in the elbow. The patient doesn't know anyone else having this problem. Are these lumps on the caller's arms lymph nodes? The caller states she has been concerned about the lumps on her arms but not concerned enough to go to the doctor. The patient stated she has not talked to anyone at her primary care physician's office yet. The patient did not visited to emergency room or physician office. It was suggested the patient go to have the lumps looked at but the patient never did. The patient asked does Pfizer have options to get rid of the swelling, to treat it? Oh, Pfizer doesn't have anything for that, the patient was giving Pfizer a chance to treat it. No relevant tests done. The outcome of the events was unknown.  Information on Lot/Batch number was available. Additional information has been requested.
Plaintiff was treated by healthcare providers for shingles, and other zoster-related conditions.; Plaintiff was treated by healthcare providers for shingles, and other zoster-related conditions.; Information was received from a lawyer regarding a case in litigation concerning a patient (pt) of unknown age and gender. The pt's medical history, concurrent conditions, or concomitant medication were not provided. In 2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) by a helthcare professional for the long term prevention of shingles and zoster-related conditions. Subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation, pt was treated by healthcare for shingles, and other zoster-related conditions. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.  The outcome of the events was not reported. The events were reported to be related to zoster vaccine live (ZOSTAVAX).
PT ADMITTED ON: 11/03/2021: The patient is admitted to the Palliative care service. HISTORY OF PRESENT ILLNESS: Patient is an 86-year-old man who had a change in level of consciousness and became dyspneic and hypoxic at the nursing home today. He is a resident at Nursing Home. He was sent to the emergency room where he has been found to certainly be hypoxic and has evidence of pneumonia on chest x-ray with a positive COVID test.  The patient himself is unable to give the history. REVIEW OF SYSTEMS: The patient is unable to complete review of systems. PAST MEDICAL HISTORY: Patient is unable to cooperate. SOCIAL HISTORY: His sister has arrived today.  Additional information for Item 18: (con't):  EXPIRED DATE: 11/05/2021: The patient expired on 11/05/2021.  ADMISSION DIAGNOSIS: COVID-19 virus infection.  FINAL DIAGNOSES: 1. Pneumonia due to COVID-19 virus. 2. Chronic obstructive bronchitis with pulmonary emphysema. 3. Aspiration pneumonia. 4. Encounter for palliative care.  HISTORY OF PRESENT ILLNESS: Patient is an 86-year-old man who presented to the hospital from a local nursing home with dyspnea.  He was evaluated in the emergency room where he was found to have right-sided pneumonia or right-sided infiltrate on chest x-ray.  He had a positive COVID test.  He had changes of emphysema on his chest x-ray.  His sister arrived in the emergency room and made it clear that she wants the care focused on his comfort.  He looked very ill in the emergency room the night that I arrived and I just did not think it was fair to put the sisters through all the hospice procedures to get the patient admitted.  I thought his death was imminent.  HOSPITAL COURSE: The patient was admitted.  He received IV morphine usually about once per shift for shortness of breath.  He expired on the morning of 11/05/2021.  The first morning after admission he actually was clinically improved and was able to say just a few words and on the morning of 11/05, he said just a few words.  He expired that morning.  Cause of death was COVID-19 pneumonia.  His sister was counseled following this.  No autopsy was desired.
Bacterial and viral pharyngitis, sinusitis.  Onset 2 days after receiving flu vaccine.
(L) thigh swollen, red at injection site. Swelling spread to surrounding skin, increased warm to touch. S/S started after injections. Suspect cellulitis. Tx with KEFLEX, BENADRYL, H 1/2 tsp q 6hrs.
Due to language barrier this patient was given the Janssen Vaccine at age 16. this was not caught until data entry. the patient has not reported any adverse reactions or complications. County Health and State Health have been notified. this report in being submitted at their direction
L Supraclavicular nodes x 2 (node #1 size of dime; node #2 size of penny); L arm soreness at injection site.; swelling at injection site.; tenderness at injection site.; This is a spontaneous report from a non-contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in left arm on 27Mar2021(at the age of 49-years-old), as a single dose for COVID-19 immunisation. Medical history included DM2, HTN, Vitamin D deficiency, seasonal allergies, eczema, catfish/nickel allergies. Concomitant medications included lisinopril; hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN), cetirizine (MANUFACTURER UNKNOWN), acetylsalicylic acid (ASA), metformin hydrochloride (METFORMIN ER), cholecalciferol (VITAMIN D3) for unknown indication from unknown date. The patient had known allergies to catfish and nickel. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Mar2021, the patient experienced L supraclavicular nodes x 2 (node #1 size of dime; node #2 size of penny); left arm soreness, swelling, tenderness at injection site. It was reported that nodes were still present at the time of this report. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events lymph nodes enlarged, left arm pain, vaccination site swelling and vaccination site pain was resolving at the time of this report.  No follow-up attempts are needed. No further information is expected.
I have developed a very pungent body odor, primarily in my armpits since receiving the first dose of the vaccine. The date I entered for symptom onset is an estimation. I do not recall when it began, but it was about 2 weeks after the first shot. I have been dealing with body odor and my armpits still feel swollen compared to before the vaccine.